Share this article on:

Editorial introductions

Section Editor(s): Fleischhacker, W. Wolfgang; DeLisi, Lynn E.

Current Opinion in Psychiatry: May 2017 - Volume 30 - Issue 3 - p v–vi
doi: 10.1097/YCO.0000000000000330
Editorial Introductions

Current Opinion in Psychiatry was launched in 1988. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of psychiatry is divided into 13 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.

Back to Top | Article Outline


W. Wolfgang Fleischhacker



W. Wolfgang Fleischhacker, MD, is Professor and Managing Director at the Department of Psychiatry and Psychotherapy, Innsbruck University Clinics in Austria. He is a certified psychiatrist and psychotherapist. After receiving his medical degree from Innsbruck University, Dr Fleischhacker trained at the Departments of Psychiatry and Neurology of the medical faculty there. In 1987 he was awarded a Fulbright Scholarship and spent 18 months at Hillside Hospital in New York.

Dr Fleischhacker is a member of the editorial boards of several peer reviewed journals, Coeditor of the ‘Schizophrenia and related disorders’ section for Current Opinion in Psychiatry, Clinical Neuropsychopharmacology Field Editor for the International Journal of Neuropsychopharmacology and Managing Editor of the Journal Neuropsychiatrie/Psychiatrie und Psychotherapie. Dr Fleischhacker's main research interests relate to schizophrenia and psychopharmacology. They have led to participation in World Health Organization and World Psychiatric Association programs focusing on schizophrenia. He is also a member of the scientific committee of the Austrian Agency for Health and Food Safety and has served as a consultant for the European Medicines Agency.

Chairman of the European Group for Research in Schizophrenia, Dr Fleischhacker is also Fellow of the International College of Neuropsychopharmacology; Fellow of the American College of Neuropsychopharmacology, Fellow of the European College of Neuropsychopharmacology. He is also a member of the Schizophrenia International Research Society, Austrian Society of Psychiatry and Psychotherapy, Austrian Schizophrenia Society, Austrian Association of Biological Psychiatry.

Back to Top | Article Outline

Lynn E. DeLisi

Lynn E

Lynn E

Lynn E. DeLisi, MD, is currently Attending Psychiatrist at the VA Boston Healthcare System and Professor of Psychiatry, Harvard Medical School, Boston, USA. In addition, she is Founding Editor-in-Chief of the Elsevier journal, Schizophrenia Research and Co-Founder and President-elevt of The Schizophrenia International Research Society (SIRS), Co-Founder and former secretary of The International Society of Psychiatric Genetics (ISPG) and a fellow of the American College of Neuropsychopharmacology (ACNP) and the American Association for the Advancement of Science (AAAS). In October 2007 and October 2013 she chaired the World Congress of Psychiatric Genetics in NYC for over 1000 participants and in 2008, 2010, 2012, and 2014 has been, along with Dr Fleischhacker, an organizer of the Schizophrenia International Research Society Conference taking place in Italy. In October 2013 she was once again co-chair of the World Congress of Psychiatric Genetics in Boston, USA.

Her undergraduate degree is in zoology from The University of Wisconsin, USA. She obtained her MD degree from the Medical College of Pennsylvania, USA and went on from there to do three years of general practice work with the migrant Chile farmers of Northern New Mexico. She completed a residency in psychiatry at Saint Elizabeth's Hospital, Washington, DC, USA and was a post-doctoral fellow and then a full-time staff research psychiatrist in the NIMH intramural research program, St. Elizabeth's Hospital (Washington, DC) and the NIH Campus (Bethesda, Maryland). In 1987, she moved to The State University of New York, USA, at Stony Brook where she set up several research programs on the longitudinal biological outcome of schizophrenia emphasizing both brain imaging and genetic studies. From 2001 through 2008 she was professor of psychiatry at New York University School of Medicine, USA and associate director of The Center for Advanced Brain Imaging at The Nathan S Kline Institute for Psychiatric Research until she obtained her current position in Boston where she has dedicated her career to research programs on detection of schizophrenia, while at the same time treating chronic patients with schizophrenia, specifically those who are Veterans of the USA Armed Forces and have had mental illness sometimes suffered as a consequence of the trauma they experienced in active combat. She also teaches and mentors several residents and trainees, both locally and internationally at congresses. She has edited and authored over 300 books and manuscripts and serves on the editorial board of several other journals.

Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.